AzTrials
AzTrials

Adequate Reporting in Published Study Protocols of Randomized Controlled TrialsSPIRIT-PRNCT05820984

A Short SPIRIT Checklist for Peer Reviewers to Improve the Reporting Quality in Published Articles (SPIRIT-PR)

A study testing SPIRIT checklist plus usual practice and Usual practice in people with Adequate Reporting in Published Study Protocols of Randomized Controlled Trials, run by University of Oxford at 1 site in United Kingdom.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Transparent and accurate reporting is key, so that readers can adequately interpreting the results of a study. The aim of this project is to evaluate whether reminding peer reviewers of the most important SPIRIT reporting items (including a short explanation of those items) will result in higher adherence to SPIRIT… Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
What is being tested?
SPIRIT checklist plus usual practice and Usual practice
Could I receive a placebo?
No, everyone receives an active treatment
How many people
178 participants
Where
1 siteUnited Kingdom
Study dates
1 Jun 2020to 30 Jun 2022
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • It was planned from the beginning that this study will only be conducted at the BMJ Open as it publishes numerous protocols. Hence, no inclusion criteria for the journal were specified.
  • All submitted manuscripts sent out for external review that described protocols for RCTs.

Who cannot join

  • We excluded (i) Manuscripts which were clearly labelled as a pilot or feasibility study (ii) Studies randomizing animals or cells (iii) Separate publications of data analysis plans
  • Included peer-reviewers:
  • -Peer reviewers that were invited following usual journal practice

Trial locations and contacts

1 site in 1 country.

United Kingdom1 site
  • The BMJ Publishing Group

    London

Other trials in United Kingdom

About this study

Official title: Impact of a Short Form of the SPIRIT Checklist for Peer Reviewers to Improve the Reporting of Protocols for Randomised Controlled Trials Published in Biomedical Journals: a Randomised Controlled Trial (SPIRIT-PR)

Transparent and accurate reporting is key, so that readers can adequately interpreting the results of a study. The aim of this project is to evaluate whether reminding peer reviewers of the most important SPIRIT reporting items (including a short explanation of those items) will result in higher adherence to SPIRIT guidelines in published protocols for RCTS. During the standard peer-review process, peer-reviewers will be randomly allocated to use either (i) a short version of the SPIRIT checklist including the ten most important and poorly reported SPIRIT items ; or (ii) no checklist. The aim is to find an intervention which improves the reporting, making it easier for readers to adequately interpret the presented articles.

Read the detailed description

The full protocol is available on Open Science Framework where the study was prospectively registered: https://osf.io/z2hm9

Being tested
SPIRIT checklist plus usual practice, Usual practice

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • SPIRIT checklist plus usual practiceOther

    Peer reviewer will be reminded of the following 10 CONSORT items (including a short description):

    Outcomes (12) Sample size (14) Recruitment (15) Allocation implementation (16 c) Blinding (17 a) Data collection methods (18 a) Data collection methods - retention (18 b) Statistical methods (20 a) Population analysed (20 c) Access to data (29)

  • Usual practiceOther

    Peer review as it is usual practice at the journal

Study groups in NCT05820984
Study groupRoleWhat they receive
SPIRIT checklist plus usual practiceExperimentalAfter accepting to review an article, peer reviewers will receive the automated, journal specific standard email with general information as per each journal's usual practice (e.g. where to access the manuscript, date when the peer review report is due). In addition, peer-reviewers who received a manuscript which was randomised to the experimental arm will receive an additional email including a short version of the SPIRIT checklist together with a short explanation of those items.
Receives: Other: SPIRIT checklist plus usual practice
Usual practiceOtherAfter accepting to review an article, peer reviewers will receive the automated, journal specific standard email with general information as per each journal's usual practice.
Receives: Other: Usual practice

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Completeness of reporting

    The primary outcome of this study will be the difference of the mean proportion of adequately reported items of the 10 most important and poorly reported SPIRIT items between the two intervention arms.

    Measured: Through study completion, an average of 1 year

Secondary outcomes (5)
  1. Completeness of reporting

    Mean proportion of adequate reporting of the 10 most important and poorly reported SPIRIT items, considering each sub-item as a separate item.

    Measured: Through study completion, an average of 1 year

  2. Completeness of reporting

    Mean proportion for each of the 10 most important and poorly reported SPIRIT items separately (including also separate analysis of sub-items).

    Measured: Through study completion, an average of 1 year

  3. Time from assigning an academic editor until the first decision (as communicated to the author after the first round of peer-review).

    Measured: Through study completion, an average of 4 months; will be assessed from routinely collected data

  4. Proportion of articles directly rejected after the first round of peer-review

    Measured: Through study completion, an average of 4 months; will be assessed from routinely collected data

  5. Proportion of articles published

    Measured: Through study completion, an average of 9 months; will be assessed from routinely collected data

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted20 Apr 2023
  2. Study start1 Jun 2020
  3. Primary completion30 Jun 2022
  4. Study completion30 Jun 2022

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Participant
Enrolment
178 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05820984
Sponsor's protocol ID
SPIRIT-PR 2019
Acronym
SPIRIT-PR
Status last verified
Apr 2023
First submitted
19 Apr 2023
Last updated
20 Apr 2023
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: We plan to publish the anonymised data set together with the main publication.

Publications

  • Speich B, Mann E, Schonenberger CM, Mellor K, Griessbach AN, Dhiman P, Gandhi P, Lohner S, Agarwal A, Odutayo A, Puebla I, Clark A, Chan AW, Schlussel MM, Ravaud P, Moher D, Briel M, Boutron I, Schroter S, Hopewell S. Reminding Peer Reviewers of Reporting Guideline Items to Improve Completeness in Published Articles: Primary Results of 2 Randomized Trials. JAMA Netw Open. 2023 Jun 1;6(6):e2317651. doi: 10.1001/jamanetworkopen.2023.17651.

    PubMed 37294569

Questions about this trial

What is this clinical trial studying?

A study testing SPIRIT checklist plus usual practice and Usual practice in people with Adequate Reporting in Published Study Protocols of Randomized Controlled Trials, run by University of Oxford at 1 site in United Kingdom.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 20 Apr 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United Kingdom. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Completeness of reporting (time frame: Through study completion, an average of 1 year). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05820984, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 20 Apr 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in